122 related articles for article (PubMed ID: 2017054)
1. Prescription charges and the evaluation of health policies.
Smith AJ
Med J Aust; 1991 Mar; 154(5):303-4. PubMed ID: 2017054
[No Abstract] [Full Text] [Related]
2. Pharmaceutical drawbacks.
Meyers D
Med J Aust; 1979 Apr; 1(8):344. PubMed ID: 449826
[No Abstract] [Full Text] [Related]
3. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
Morgan SG; Agnew JD; Barer ML
Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
[TBL] [Abstract][Full Text] [Related]
4. Cost-sharing for prescription drugs.
Gibson TB; McLaughlin CG; Smith DG
JAMA; 2001 May; 285(18):2328-9. PubMed ID: 11343477
[No Abstract] [Full Text] [Related]
5. Gift giving.
Raszkowski RR
S D J Med; 2002 Dec; 55(12):513-4. PubMed ID: 12516357
[No Abstract] [Full Text] [Related]
6. 24th annual prescription survey, Albany College of Pharmacy.
DeNuzzo RV
Med Mark Media; 1980 Apr; 15(4):17-36. PubMed ID: 10245963
[No Abstract] [Full Text] [Related]
7. Medicaid's new prescription drug legislation: prudent purchasing and drug use review.
Coster JM
Alaska Med; 1991; 33(4):147-50. PubMed ID: 1816731
[No Abstract] [Full Text] [Related]
8. Medicaid prescription drug utilization and expenditures following Part D.
Farley JF; Dusetzina SB
J Health Care Poor Underserved; 2010 May; 21(2):715-28. PubMed ID: 20453368
[TBL] [Abstract][Full Text] [Related]
9. Prescription pricing across Canada (Part II).
Archer F
CPJ; 1984 Sep; 117(9):434-5. PubMed ID: 10268225
[TBL] [Abstract][Full Text] [Related]
10. PBS charges.
Harvey K
Med J Aust; 1991 Mar; 154(5):364-5. PubMed ID: 2017069
[No Abstract] [Full Text] [Related]
11. General practitioner prescribing rates and costs.
Malcolm LA; Higgins CS
N Z Med J; 1981 May; 93(683):301-3. PubMed ID: 6942285
[TBL] [Abstract][Full Text] [Related]
12. Prescription drug pricing: the consumer perspective.
Searing A
N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
[No Abstract] [Full Text] [Related]
13. Prescription charges.
Birch S
J R Coll Gen Pract; 1986 Oct; 36(291):473. PubMed ID: 3440993
[No Abstract] [Full Text] [Related]
14. Time will judge 'scary' dispensing regulations.
Bateman C
S Afr Med J; 2004 Oct; 94(10):809-10, 812. PubMed ID: 15532750
[No Abstract] [Full Text] [Related]
15. The rising utilization and costs of prescription drugs.
PHC4 FYI; 2004; (26):1-2. PubMed ID: 15344277
[No Abstract] [Full Text] [Related]
16. Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden.
Rudholm N
Scand J Public Health; 2005; 33(1):50-6. PubMed ID: 15764241
[TBL] [Abstract][Full Text] [Related]
17. Polypharmacy: its cost burden and barrier to medical care in a drug-oriented health care system.
Isenalumhe AE; Oviawe O
Int J Health Serv; 1988; 18(2):335-42. PubMed ID: 3132431
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical costs. An overview and analysis of legal and policy responses by the states.
Latham SR
J Leg Med; 2003 Jun; 24(2):141-73. PubMed ID: 12775406
[No Abstract] [Full Text] [Related]
19. Relationship between increasing prescription charges and consumption in groups not exempt from charges.
Birch S
J R Coll Gen Pract; 1986 Apr; 36(285):154-6. PubMed ID: 3735198
[TBL] [Abstract][Full Text] [Related]
20. [Drug utilization decisions should be based on cost-benefit data].
Bengt J; Arvidsson G; Levin LA; Rehnberg C
Lakartidningen; 2005 Apr 18-24; 102(16):1264-5; discussion 1265. PubMed ID: 15921102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
